HEMACAPE ApS: Financial statements 2025
CVR: 35817115
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
HEMACAPE ApS (CVR 35817115) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -5,843 and a net result of DKK 537,377 compared with DKK -3,750 the year before. Equity in the 2025 report amounted to DKK 612,350. The solvency ratio was 57.5%.
- Gross Profit
- DKK -5,843
- Profit/Loss
- DKK 537,377
- Equity
- DKK 612,350
- Total Assets
- DKK 1,064,293
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -6 t. | 537 t. | 612 t. | 0 |
| 2024 | - | -4 t. | -4 t. | 75 t. | 1 |
| 2023 | - | -4 t. | -4 t. | 79 t. | - |
| 2022 | - | -4 t. | -4 t. | 82 t. | 0 |
| 2021 | - | -3 t. | -4 t. | 86 t. | 0 |
Official annual report
How creditworthy is HEMACAPE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
HEMACAPE ApS has published its annual report for 2024. Gross profit came to DKK -3,750, and the net result was DKK -3,750.
About HEMACAPE ApS
HEMACAPE ApS is a Danish company of the type Anpartsselskab based in Randers NØ, founded in 2014. The company is registered under the industry Anden finansiel formidling i.a.n.. The management consists of John Holflod Jeppesen. The company is owned by John Holflod Jeppesen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -5,843 and a net result of DKK 537,377 compared with DKK -3,750 the year before. Equity in the 2025 report amounted to DKK 612,350.